Neurocognitive & Delirium
Medication-Induced Movement
Full criteria not included in this record
Full criteria not included in this record
Full criteria not included in this record
Full criteria not included in this record
A. ≥3 of 12 catatonia symptoms: stupor; catalepsy; waxy flexibility; mutism; negativism; posturing; mannerism; stereotypy; agitation; grimacing; echolalia; echopraxia B. Associated with another mental disorder / due to another medical condition / unspecified (determines specifier applied)
A. Dopamine antagonist exposure (antipsychotic or antiemetic) and development of severe muscle rigidity and elevated temperature B. ≥2 of: diaphoresis; dysphagia; tremor; incontinence; change in level of consciousness (confusion to coma); mutism; tachycardia; elevated/labile BP; leukocytosis; elevated CK C. Not attributable to another substance or medical/neurological condition
Catatonia associated with another mental disorder; Catatonic disorder due to another medical condition; Unspecified catatonia; With stupor
Associated with antipsychotic exposure; Associated with dopaminergic withdrawal; With severe rhabdomyolysis; Severity (Mild / Moderate / Severe)
NMS (fever, rigidity, markedly elevated CK - urgent); Serotonin syndrome (hyperthermia, clonus, diaphoresis); Non-convulsive status epilepticus (EEG essential)
Serotonin syndrome (hyperthermia + clonus + diaphoresis + hyperreflexia - starts within 24 hrs; clonus distinguishes from NMS rigidity); Malignant hyperthermia (anaesthetic trigger; volatile agents/suxamethonium; ryanodine receptor mutation); Lethal catatonia (treatment with ECT; NMS and lethal catatonia may overlap)